Kanonji, Japan

Tetsuo Onoda

This inventor holds 1 USPTO granted patent. Top assignee: Osaka University. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuo Onoda. Retrieved from https://idiyas.com/inventor/tetsuo-onoda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 101(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tetsuo Onoda: Innovator in Vaccine Development

Introduction

Tetsuo Onoda is a notable inventor based in Kanonji, Japan. He has made significant contributions to the field of vaccine development, particularly in the preparation of live vaccines for virus diseases. His innovative approach has implications for both animal and human health.

Latest Patents

Onoda holds a patent for a "Process for preparing virus disease live vaccines." This process involves the use of quail embryonated eggs or tissue culture of quail embryo fibroblasts for the cultivation of the virus. The resulting vaccine is effective for immunization against virus diseases and is characterized as avirulent, minimizing the risk of adverse effects. Additionally, it is economically viable for production.

Career Highlights

Tetsuo Onoda is affiliated with Osaka University, where he continues to engage in research and development in the field of virology and immunology. His work has been instrumental in advancing vaccine technology, contributing to public health initiatives.

Collaborations

Onoda has collaborated with notable colleagues, including Koichi Ono and Takeo Konobe. Their joint efforts have furthered research in vaccine development and have led to advancements in the field.

Conclusion

Tetsuo Onoda's contributions to vaccine development highlight the importance of innovative approaches in combating viral diseases. His work not only benefits the scientific community but also has a lasting impact on public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…